Quick Answer
Clearmind Medicine Inc. reported R&D Expense of $2.06 million for fiscal year 2025.
Clearmind Medicine Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $2.06M | +48.7% |
| 2024 | $1.38M | -10.5% |
| 2023 | $1.54M | -49.9% |
| 2022 | $3.08M | +550.5% |
| 2021 | $473.7K | — |
- Clearmind Medicine Inc. showed an increase of +48.7% in R&D Expense compared to the prior fiscal year.
- Over the 2021–2025 period, Clearmind Medicine Inc.’s r&d expense has grown by 334.2% (from $473.7 thousand to $2.06 million).
- The most recent figure is from Clearmind Medicine Inc.’s fiscal year 2025 report (Form 20-F), filed with the SEC on January 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: